The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
Triple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to tre...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841527804820193280 |
---|---|
author | Ziyi Chen Yi Zhao Yi Zhao |
author_facet | Ziyi Chen Yi Zhao Yi Zhao |
author_sort | Ziyi Chen |
collection | DOAJ |
description | Triple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to treatments and extremely invasive characteristics. The typical treatment for TNBC frequently results in relapse because of the lack of particular treatment choices. It is urgent to focus on identifying a workable and effective target for the treatment of TNBC. Cancer metastasis is significantly influenced by epithelial-mesenchymal transition (EMT). Ferroptosis is an iron-dependent cell death form, and changes its key factor to affect the proliferation and metastasis of TNBC. Several reports have established associations between EMT and ferroptosis in TNBC metastasis. Furthermore, non-coding RNA (ncRNA), which has been previously described, can also control cancer cell death and metastasis. Thus, in this review, we summarize the correlation and pathways among the ferroptosis, EMT, and ncRNAs in TNBC metastasis. Also, aim to find out a novel strategy for TNBC treatment through the ncRNA-ferroptosis-EMT axis. |
format | Article |
id | doaj-art-1abe67d2fd5949f2a8ce16b9c567a435 |
institution | Kabale University |
issn | 1663-9812 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj-art-1abe67d2fd5949f2a8ce16b9c567a4352025-01-15T06:10:37ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14370221437022The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAsZiyi Chen0Yi Zhao1Yi Zhao2Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaKey Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Healthcare Hospital of Shandong Province Affiliated to Qingdao University, Jinan, Shandong, ChinaTriple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to treatments and extremely invasive characteristics. The typical treatment for TNBC frequently results in relapse because of the lack of particular treatment choices. It is urgent to focus on identifying a workable and effective target for the treatment of TNBC. Cancer metastasis is significantly influenced by epithelial-mesenchymal transition (EMT). Ferroptosis is an iron-dependent cell death form, and changes its key factor to affect the proliferation and metastasis of TNBC. Several reports have established associations between EMT and ferroptosis in TNBC metastasis. Furthermore, non-coding RNA (ncRNA), which has been previously described, can also control cancer cell death and metastasis. Thus, in this review, we summarize the correlation and pathways among the ferroptosis, EMT, and ncRNAs in TNBC metastasis. Also, aim to find out a novel strategy for TNBC treatment through the ncRNA-ferroptosis-EMT axis.https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/fullferroptosisEMTbreast cancernon-coding RNAmetastasis |
spellingShingle | Ziyi Chen Yi Zhao Yi Zhao The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs Frontiers in Pharmacology ferroptosis EMT breast cancer non-coding RNA metastasis |
title | The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs |
title_full | The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs |
title_fullStr | The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs |
title_full_unstemmed | The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs |
title_short | The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs |
title_sort | mechanism underlying metastasis in triple negative breast cancer focusing on the interplay between ferroptosis epithelial mesenchymal transition and non coding rnas |
topic | ferroptosis EMT breast cancer non-coding RNA metastasis |
url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/full |
work_keys_str_mv | AT ziyichen themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas AT yizhao themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas AT yizhao themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas AT ziyichen mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas AT yizhao mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas AT yizhao mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas |